"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

Currently, Ozempic is only approved to treat type 2 diabetes. But in recent years, the semaglutide injection has become a ...

the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that "several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg" were in the U.S ...

Novo Nordisk cautions pharmacies and individuals to only purchase Ozempic® (semaglutide) injection 1 mg and other semaglutide-containing medicines through authorized distributors of Novo ...

The manufacture advices retail pharmacies to purchase authentic Ozempic (semaglutide) injection 1 mg and other semaglutide-containing medicines through authorized distributors of Novo Nordisk.

Current Status of GLP-1 Medications The FDA has officially determined that the shortage of both semaglutide and tirzepatide injection products is now resolved. Semaglutide: The FDA determined on ...